Thus, a PAI-1 inhibitor as a single agent is useful as a PD-L1 expression inhibitor, immune stimulator, ICI of PD-L1, inhibitor of tumor cell exacerbation caused by PD-L1, and enhancer of tumor immunotherapy. The gene discussed is CD274; the disease is neoplasm.